AIMS: In patients with paroxysmal atrial fibrillation (pAF), pulmonary vein isolation (PVI) has become an accepted treatment option with single procedure success rates of 60-80%. A repeat ablation is performed in ∼30% of patients because of arrhythmia recurrence. The strategy for this repeat procedure is not defined. METHODS AND RESULTS:Patients with pAF recurrence after PVI were prospectively randomized and underwent a second ablation procedure with either PVI of all reconnected veins or PVI with an additional left atrial anterior line. Follow-up in our arrhythmia clinic was every 3 months up to 12 months including 7 day Holter monitoring. A total of 77 patients (mean age 63 ± 9 years, 69% males) were included in the analysis. A repeat PVI was performed in 41 patients, PVI + anterior line in 36 patients. After a follow-up of 12 months, 26 of 41 (63%) patients after repeat PVI and 18 of 36 (50%) patients with PVI + anterior line were in stable sinus rhythm off antiarrhythmic medication (P = 0.26). In most patients (12 of 15 patients with PVI and 14 of 18 patients with PVI + anterior line) with an arrhythmia recurrence after the second procedure, the recurring arrhythmia was paroxysmal AF. In 2 of 15 patients of the PVI group and in 4 of 18 patients of the PVI + anterior line group atypical flutter was the reoccurring arrhythmia (P = NS). CONCLUSION: In this prospective randomized trial, patients with a recurrence of paroxysmal AF had no better outcome after repeat PVI + one left atrial line compared with patients with repeat PVI only. Published on behalf of the European Society of Cardiology. All rights reserved.
RCT Entities:
AIMS: In patients with paroxysmal atrial fibrillation (pAF), pulmonary vein isolation (PVI) has become an accepted treatment option with single procedure success rates of 60-80%. A repeat ablation is performed in ∼30% of patients because of arrhythmia recurrence. The strategy for this repeat procedure is not defined. METHODS AND RESULTS:Patients with pAF recurrence after PVI were prospectively randomized and underwent a second ablation procedure with either PVI of all reconnected veins or PVI with an additional left atrial anterior line. Follow-up in our arrhythmia clinic was every 3 months up to 12 months including 7 day Holter monitoring. A total of 77 patients (mean age 63 ± 9 years, 69% males) were included in the analysis. A repeat PVI was performed in 41 patients, PVI + anterior line in 36 patients. After a follow-up of 12 months, 26 of 41 (63%) patients after repeat PVI and 18 of 36 (50%) patients with PVI + anterior line were in stable sinus rhythm off antiarrhythmic medication (P = 0.26). In most patients (12 of 15 patients with PVI and 14 of 18 patients with PVI + anterior line) with an arrhythmia recurrence after the second procedure, the recurring arrhythmia was paroxysmal AF. In 2 of 15 patients of the PVI group and in 4 of 18 patients of the PVI + anterior line group atypical flutter was the reoccurring arrhythmia (P = NS). CONCLUSION: In this prospective randomized trial, patients with a recurrence of paroxysmal AF had no better outcome after repeat PVI + one left atrial line compared with patients with repeat PVI only. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Gavin S Chu; Xin Li; Peter J Stafford; Frederique J Vanheusden; João L Salinet; Tiago P Almeida; Nawshin Dastagir; Alastair J Sandilands; Paulus Kirchhof; Fernando S Schlindwein; G André Ng Journal: Front Physiol Date: 2022-03-16 Impact factor: 4.755
Authors: Juan-Pablo Abugattas; Bruno Schwagten; Jeroen De Cocker; Hugo-Enrique Coutiño; Francesca Salghetti; Varnavas Varnavas; Erwin Ströker; Juan Sieira; Michael Wolf; Pedro Brugada; Carlo de Asmundis; Gian-Battista Chierchia; Yves De Greef Journal: J Atr Fibrillation Date: 2019-02-28
Authors: Stephanie Fichtner; Reza Wakili; Konstantinos Rizas; Johannes Siebermair; Moritz F Sinner; Thomas Wiktor; Korbinian Lackermair; Franziska Schuessler; Lucia Olesch; Susanne Rainer; Stefan Kääb; Adrian Curta; Harald Kramer; Heidi L Estner Journal: Biomed Res Int Date: 2018-09-18 Impact factor: 3.411
Authors: Xin Li; Gavin S Chu; Tiago P Almeida; Frederique J Vanheusden; João Salinet; Nawshin Dastagir; Amar R Mistry; Zakariyya Vali; Bharat Sidhu; Peter J Stafford; Fernando S Schlindwein; G André Ng Journal: Front Physiol Date: 2021-03-12 Impact factor: 4.566
Authors: Daniel Mol; Mark J Mulder; Rob Veenstra; Cornelis P Allaart; Irene E Hof; Michiel J B Kemme; Muchtiar Khan; Geert-Jan P Kimman; Gideon Mairuhu; Gijsbert S de Ruiter; Giovanni J M Tahapary; Joris R de Groot; Jonas S S G de Jong Journal: J Cardiovasc Electrophysiol Date: 2022-03-22 Impact factor: 2.942
Authors: Mahmoud Ehnesh; Xin Li; Tiago P Almeida; Gavin S Chu; Nawshin Dastagir; Peter J Stafford; G André Ng; Fernando S Schlindwein Journal: Front Physiol Date: 2022-08-05 Impact factor: 4.755